Group A (49) | Group B (85) | p | |
---|---|---|---|
Age (mean) | 40,2 | 66,0 | 0.001 |
Symptoms | 93,8% | 62,3% | 0.031 |
Extended surgery* | 9,7% | 9,4% | 0.965 |
Proximal localization** | 38,7% | 34,1% | 0.647 |
Mucinous | 16,1% | 14,1% | 0.786 |
Advanced stage (T3-4) | 61,3% | 37,6% | 0.023 |
Undifferentiated | 32,2% | 9,4% | 0.0026 |
Disease free survival (mean) | 73 m | 81 m | 0.78 |
Overall survival (mean) | 79 m | 89 m | 0.86 |